Loading...
Header Logo
Keywords
Last Name
Institution

MARTIN KORBLING

TitleProfessor
InstitutionMD Anderson
DepartmentStem Cell Transplantation
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chahoud J, Sui D, Erwin WD, Gulbis AM, Korbling M, Zhang M, Ahmed S, Alatrash G, Anderlini P, Ciurea SO, Oran B, Fayad LE, Bassett RL, Jabbour EJ, Medeiros LJ, Macapinlac HA, Young KH, Khouri IF. Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2018 05 15; 24(10):2304-2311. PMID: 29476021.
      View in: PubMed
    2. Oran B, Saliba RM, Carmazzi Y, de Lima M, Rondon G, Ahmed S, Alousi A, Andersson BS, Anderlini P, Alvarez M, Bashir Q, Ciurea S, Fernandez-Vina M, Hosing C, Kebriaei P, Korbling M, Cano P, Khouri I, Marin D, Nieto Y, Olson A, Popat U, Rezvani K, Qazilbash M, Shpall EJ, Champlin RE, Cao K. Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion. Blood. 2018 03 15; 131(11):1248-1257. PMID: 29386198.
      View in: PubMed
    3. Khouri MR, Jabbour EJ, Gulbis AM, Turturro F, Ledesma C, Korbling M, Samuels BI, Ahmed S, Alousi AM, Ciurea SO, Marin D, Patel KK, Popat UR, Bueso-Ramos CE, Bassett RL, Khouri IF. Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017 Aug; 23(8):1405-1410. PMID: 28495642.
      View in: PubMed
    4. Bock F, Lu G, Srour SA, Gaballa S, Lin HY, Baladandayuthapani V, Honhar M, Stich M, Shah ND, Bashir Q, Patel K, Popat U, Hosing C, Korbling M, Delgado R, Rondon G, Shah JJ, Thomas SK, Manasanch EE, Isermann B, Orlowski RZ, Champlin RE, Qazilbash MH. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 12; 22(12):2159-2164. PMID: 27638366.
      View in: PubMed
    5. Gaballa S, Ge I, El Fakih R, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, Rondon G, Chen J, Hammerstrom A, Lombardi L, Alatrash G, Korbling M, Oran B, Kebriaei P, Ahmed S, Shah N, Rezvani K, Marin D, Bashir Q, Alousi A, Nieto Y, Qazilbash M, Hosing C, Popat U, Shpall EJ, Khouri I, Champlin RE, Ciurea SO. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer. 2016 Nov 15; 122(21):3316-3326. PMID: 27404668.
      View in: PubMed
    6. Beitinjaneh A, Saliba RM, Medeiros LJ, Turturro F, Rondon G, Korbling M, Fayad L, Fanale MA, Alousi AM, Anderlini P, Betul O, Popat UR, Pro B, Khouri IF. Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease. Biol Blood Marrow Transplant. 2015 May; 21(5):855-9. PMID: 25652691.
      View in: PubMed
    7. Khouri IF, Wei W, Korbling M, Turturro F, Ahmed S, Alousi A, Anderlini P, Ciurea S, Jabbour E, Oran B, Popat UR, Rondon G, Bassett RL, Gulbis A. BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD. Blood. 2014 Oct 02; 124(14):2306-12. PMID: 25145344.
      View in: PubMed
    8. Poon ML, Fox PS, Samuels BI, O'Brien S, Jabbour E, Hsu Y, Gulbis A, Korbling M, Champlin R, Abruzzo LV, Bassett RL, Khouri IF. Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis. Leuk Lymphoma. 2015 Mar; 56(3):711-5. PMID: 24913509.
      View in: PubMed
    9. Chakhachiro ZI, Saliba RM, Okoroji GJ, Korbling M, Alousi AM, Betul O, Anderlini P, Ciurea SO, Popat U, Champlin R, Samuels BI, Medeiros LJ, Bueso-Ramos C, Khouri IF. Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission. Cancer. 2013 Sep 15; 119(18):3318-25. PMID: 23775587.
      View in: PubMed
    10. de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med. 2012 Dec 13; 367(24):2305-15. PMID: 23234514.
      View in: PubMed
    11. Ciurea SO, Mulanovich V, Saliba RM, Bayraktar UD, Jiang Y, Bassett R, Wang SA, Konopleva M, Fernandez-Vina M, Montes N, Bosque D, Chen J, Rondon G, Alatrash G, Alousi A, Bashir Q, Korbling M, Qazilbash M, Parmar S, Shpall E, Nieto Y, Hosing C, Kebriaei P, Khouri I, Popat U, de Lima M, Champlin RE. Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1835-44. PMID: 22796535.
      View in: PubMed
    12. Khouri IF, Saliba RM, Erwin WD, Samuels BI, Korbling M, Medeiros LJ, Valverde R, Alousi AM, Anderlini P, Bashir Q, Ciurea S, Gulbis AM, de Lima M, Hosing C, Kebriaei P, Popat UR, Fowler N, Neelapu SS, Samaniego F, Champlin RE, Macapinlac HA. Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results. Blood. 2012 Jun 28; 119(26):6373-8. PMID: 22586182.
      View in: PubMed
    13. Ciurea SO, Thall PF, Wang X, Wang SA, Hu Y, Cano P, Aung F, Rondon G, Molldrem JJ, Korbling M, Shpall EJ, de Lima M, Champlin RE, Fernandez-Vina M. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 2011 Nov 24; 118(22):5957-64. PMID: 21967975.
      View in: PubMed
    14. Körbling M, Freireich EJ. Twenty-five years of peripheral blood stem cell transplantation. Blood. 2011 Jun 16; 117(24):6411-6. PMID: 21460243.
      View in: PubMed
    15. Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, Wang X, Thall PF, Champlin RE, Fernandez-Vina M. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation. 2009 Oct 27; 88(8):1019-24. PMID: 19855248.
      View in: PubMed
    16. Ciurea SO, Saliba R, Rondon G, Pesoa S, Cano P, Fernandez-Vina M, Qureshi S, Worth LL, McMannis J, Kebriaei P, Jones RB, Korbling M, Qazilbash M, Shpall EJ, Giralt S, de Lima M, Champlin RE, Gajewski J. Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplant. 2010 Mar; 45(3):429-36. PMID: 19668237.
      View in: PubMed
    17. Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, De Lima M, Okoroji JG, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I, Popat U. Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. Am J Hematol. 2009 Jun; 84(6):335-7. PMID: 19384931.
      View in: PubMed
    18. Popat U, Saliba R, Thandi R, Hosing C, Qazilbash M, Anderlini P, Shpall E, McMannis J, Körbling M, Alousi A, Andersson B, Nieto Y, Kebriaei P, Khouri I, de Lima M, Weber D, Thomas S, Wang M, Jones R, Champlin R, Giralt S. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant. 2009 Jun; 15(6):718-23. PMID: 19450756.
      View in: PubMed
    19. Tam CS, Bassett R, Ledesma C, Korbling M, Alousi A, Hosing C, Kebraei P, Harrell R, Rondon G, Giralt SA, Anderlini P, Popat U, Pro B, Samuels B, Hagemeister F, Medeiros LJ, Champlin RE, Khouri IF. Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma. Blood. 2009 Apr 30; 113(18):4144-52. PMID: 19168784.
      View in: PubMed
    20. Alousi AM, Saliba RM, Okoroji GJ, Macapinlac HA, Hosing C, Korbling M, Samuels BI, Popat U, Kebriaei P, Anderlini P, Qazilbash MH, de Lima M, Giralt SA, Champlin RE, Khouri IF. Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation. Br J Haematol. 2008 Sep; 142(5):786-92. PMID: 18564354.
      View in: PubMed
    21. Andersson BS, de Lima M, Thall PF, Wang X, Couriel D, Korbling M, Roberson S, Giralt S, Pierre B, Russell JA, Shpall EJ, Jones RB, Champlin RE. Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. Biol Blood Marrow Transplant. 2008 Jun; 14(6):672-84. PMID: 18489993.
      View in: PubMed
    22. Khouri IF, McLaughlin P, Saliba RM, Hosing C, Korbling M, Lee MS, Medeiros LJ, Fayad L, Samaniego F, Alousi A, Anderlini P, Couriel D, de Lima M, Giralt S, Neelapu SS, Ueno NT, Samuels BI, Hagemeister F, Kwak LW, Champlin RE. Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab. Blood. 2008 Jun 15; 111(12):5530-6. PMID: 18411419.
      View in: PubMed
    23. Körbling M, de Lima MJ, Thomas E, Khanna A, Najjar AM, Gu J, Gelovani JG, Broaddus R. Fusion of circulating blood cells with solid-organ tissue cells in clinical stem cell transplants: a potential therapeutic model? Regen Med. 2008 Mar; 3(2):157-64. PMID: 18307399.
      View in: PubMed
    24. Khouri IF, Saliba RM, Admirand J, O'Brien S, Lee MS, Korbling M, Samuels BI, Giralt S, Lima de M, Keating MJ, Champlin RE, Bueso-Ramos C. Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia. Br J Haematol. 2007 May; 137(4):355-63. PMID: 17456058.
      View in: PubMed
    25. Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, Wei C, Anderlini P, Popat U, Shpall E, Giralt S, Champlin RE. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant. 2007 Apr; 13(4):469-77. PMID: 17382253.
      View in: PubMed
    26. Körbling M, Reuben JM, Gao H, Lee BN, Harris DM, Cogdell D, Giralt SA, Khouri IF, Saliba RM, Champlin RE, Zhang W, Estrov Z. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion. 2006 Oct; 46(10):1795-802. PMID: 17002637.
      View in: PubMed
    27. Lekakis L, Giralt S, Couriel D, Shpall EJ, Hosing C, Khouri IF, Anderlini P, Korbling M, Martin T, Champlin RE, de Lima M. Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant. 2006 Sep; 38(6):421-6. PMID: 16892072.
      View in: PubMed
    28. Hosing C, Saliba RM, Körbling M, Acholonu S, McMannis J, Anderlini P, Giralt S, De Lima M, Okoroji GJ, Couriel DR, Champlin R, Khouri IF, Donato ML. High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Jul; 47(7):1290-4. PMID: 16923559.
      View in: PubMed
    29. Hosing C, Qazilbash MH, Kebriaei P, Giralt S, Davis MS, Popat U, Anderlini P, Shpall EJ, McMannis J, Körbling M, Champlin RE. Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. Br J Haematol. 2006 Jun; 133(5):533-7. PMID: 16681642.
      View in: PubMed
    30. Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z. Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J Vasc Res. 2005 Sep-Oct; 42(5):408-14. PMID: 16088214.
      View in: PubMed
    31. Khouri IF, Saliba RM, Hosing C, Okoroji GJ, Acholonu S, Anderlini P, Couriel D, De Lima M, Donato ML, Fayad L, Giralt S, Jones R, Korbling M, Maadani F, Manning JT, Pro B, Shpall E, Younes A, McLaughlin P, Champlin RE. Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas. J Clin Oncol. 2005 Apr 01; 23(10):2240-7. PMID: 15800314.
      View in: PubMed
    32. Körbling M, Robinson S, Estrov Z, Champlin R, Shpall E. Umbilical cord blood-derived cells for tissue repair. Cytotherapy. 2005; 7(3):258-61. PMID: 16081352.
      View in: PubMed
    33. Obeyesekere MN, Berry RW, Spicer PP, Korbling M. A mathematical model of haemopoiesis as exemplified by CD34 cell mobilization into the peripheral blood. Cell Prolif. 2004 Aug; 37(4):279-94. PMID: 15245564.
      View in: PubMed
    34. Reuben JM, Korbling M, Gao H, Lee BN. The effect of low dose gamma irradiation on the differentiation and maturation of monocyte derived dendritic cells. J Gravit Physiol. 2004 Jul; 11(2):P49-52. PMID: 16231453.
      View in: PubMed
    35. de Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R, Shpall EJ, Shahjahan M, Pierre B, Giralt S, Korbling M, Russell JA, Champlin RE, Andersson BS. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood. 2004 Aug 01; 104(3):857-64. PMID: 15073038.
      View in: PubMed
    36. Hennessy B, Körbling M, Estrov Z. Circulating stem cells and tissue repair. Panminerva Med. 2004 Mar; 46(1):1-11. PMID: 15238877.
      View in: PubMed
    37. Pentz RD, Chan KW, Neumann JL, Champlin RE, Korbling M. Designing an ethical policy for bone marrow donation by minors and others lacking capacity. Camb Q Healthc Ethics. 2004; 13(2):149-55. PMID: 15124402.
      View in: PubMed
    38. Monaco G, Konopleva M, Munsell M, Leysath C, Wang RY, Jackson CE, Korbling M, Estey E, Belmont J, Andreeff M. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival. Stem Cells. 2004; 22(2):188-201. PMID: 14990858.
      View in: PubMed
    39. Khouri IF, Lee MS, Saliba RM, Andersson B, Anderlini P, Couriel D, Hosing C, Giralt S, Korbling M, McMannis J, Keating MJ, Champlin RE. Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival. Exp Hematol. 2004 Jan; 32(1):28-35. PMID: 14725898.
      View in: PubMed
    40. Yeh ET, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation. 2003 Oct 28; 108(17):2070-3. PMID: 14568894.
      View in: PubMed
    41. Kørbling M, Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med. 2003 Aug 07; 349(6):570-82. PMID: 12904523.
      View in: PubMed
    42. Körbling M, Estrov Z, Champlin R. Adult stem cells and tissue repair. Bone Marrow Transplant. 2003 Aug; 32 Suppl 1:S23-4. PMID: 12931235.
      View in: PubMed
    43. Duzkale H, Pagliaro LC, Rosenblum MG, Varan A, Liu B, Reuben J, Wierda WG, Korbling M, McMannis JD, Glassman AB, Scheinberg DA, Freireich EJ. Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel. Biol Blood Marrow Transplant. 2003 Jun; 9(6):364-72. PMID: 12813444.
      View in: PubMed
    44. Apisarnthanarax N, Donato M, Körbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant. 2003 Mar; 31(6):459-65. PMID: 12665841.
      View in: PubMed
    45. De Lima M, St John LS, Wieder ED, Lee MS, McMannis J, Karandish S, Giralt S, Beran M, Couriel D, Korbling M, Bibawi S, Champlin R, Komanduri KV. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol. 2002 Dec; 119(3):773-6. PMID: 12437658.
      View in: PubMed
    46. Anderlini P, Chan FA, Champlin RE, Körbling M, Strom SS. Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplant. 2002 Nov; 30(10):661-3. PMID: 12420204.
      View in: PubMed
    47. Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P, Molldrem J, Ueno NT, Donato M, Korbling M, Gajewski J, Alexanian R, Champlin R. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. Bone Marrow Transplant. 2002 Sep; 30(6):367-73. PMID: 12235521.
      View in: PubMed
    48. Esmaeli B, Ahmadi MA, Kim S, Onan H, Korbling M, Anderlini P. Marginal keratitis associated with administration of filgrastim and sargramostim in a healthy peripheral blood progenitor cell donor. Cornea. 2002 Aug; 21(6):621-2. PMID: 12131046.
      View in: PubMed
    49. Brouard M, Barrandon Y. Male cells in female recipients of hematopoietic-cell transplants. N Engl J Med. 2002 Jul 18; 347(3):218-20; author reply 218-20. PMID: 12124415.
      View in: PubMed
    50. Abdallah A, Egerer G, Weber-Nordt RM, Körbling M, Haas R, Ho AD. Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia. Bone Marrow Transplant. 2002 Jul; 30(1):15-22. PMID: 12105772.
      View in: PubMed
    51. Körbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, Albitar M, Champlin RE, Estrov Z. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002 Mar 07; 346(10):738-46. PMID: 11882729.
      View in: PubMed
    52. Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Ann Oncol. 2002 Mar; 13(3):450-9. PMID: 11996478.
      View in: PubMed
    53. Shimoni A, Körbling M. Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance? Crit Rev Oncol Hematol. 2002 Feb; 41(2):241-50. PMID: 11856599.
      View in: PubMed
    54. Estrov Z, Huh YO, Ginsberg CF, Harris D, Van Q, Mirza NQ, Talpaz M, Korbling M. Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors. J Clin Apher. 2002; 17(1):7-16. PMID: 11948700.
      View in: PubMed
    55. Gajewski JL, Rondon G, Donato ML, Anderlini P, Korbling M, Ippoliti C, Benyunes M, Miller LL, LaTemple D, Jones D, Ashby M, Hellmann S, Durett A, Lauppe J, Geisler D, Khouri IF, Giralt SA, Andersson B, Ueno NT, Champlin R. Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization. Biol Blood Marrow Transplant. 2002; 8(10):550-6. PMID: 12434950.
      View in: PubMed
    56. Hester J. RE: Therapeutic plasma exchange: a paired comparison of Fresenius AS104 vs. COBE Spectra. J Clin Apher. 2002; 17(1):49. PMID: 11948708.
      View in: PubMed
    57. Khouri IF, Saliba RM, Giralt SA, Lee MS, Okoroji GJ, Hagemeister FB, Korbling M, Younes A, Ippoliti C, Gajewski JL, McLaughlin P, Anderlini P, Donato ML, Cabanillas FF, Champlin RE. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood. 2001 Dec 15; 98(13):3595-9. PMID: 11739162.
      View in: PubMed
    58. Körbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood. 2001 Nov 15; 98(10):2900-8. PMID: 11698269.
      View in: PubMed
    59. Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, Donato M, Pierce S, Keating MJ, Freireich EJ, Estey E. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival. Leuk Lymphoma. 2001 Jun; 42(1-2):67-73. PMID: 11699223.
      View in: PubMed
    60. Przepiorka D, Smith TL, Folloder J, Anderlini P, Chan KW, Körbling M, Lichtiger B, Norfleet F, Champlin R. Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors. Blood. 2001 Jun 01; 97(11):3405-10. PMID: 11369630.
      View in: PubMed
    61. Ravandi F, Kantarjian H, Cohen A, Davis M, O'Brien S, Anderlini P, Andersson B, Claxton D, Donato M, Gajewski J, Khouri I, Korbling M, Ueno N, deVos D, Champlin R, Giralt S. Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study. Bone Marrow Transplant. 2001 Jun; 27(12):1221-5. PMID: 11548839.
      View in: PubMed
    62. Shimoni A, Smith TL, Aleman A, Weber D, Dimopoulos M, Anderlini P, Andersson B, Claxton D, Ueno NT, Khouri I, Donato M, Korbling M, Alexanian R, Champlin R, Giralt S. Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma. Bone Marrow Transplant. 2001 Apr; 27(8):821-8. PMID: 11477439.
      View in: PubMed
    63. Abdallah A, Egerer G, Goldschmidt H, Wannenmacher M, Körbling M, Ho AD. Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation. Br J Haematol. 2001 Mar; 112(4):1012-5. PMID: 11298600.
      View in: PubMed
    64. Körbling M, Giralt S, Khouri I, Mirza N, Donato M, Anderlini P, Fischer H, Andreeff M, McMannis J, Champlin R. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis. J Clin Apher. 2001; 16(2):82-7. PMID: 11746533.
      View in: PubMed
    65. Shimoni A, Gajewski JA, Donato M, Martin T, O'Brien S, Talpaz M, Cohen A, Korbling M, Champlin R, Giralt S. Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant. 2001; 7(10):568-75. PMID: 11760089.
      View in: PubMed
    66. Shimoni A, Körbling M, Champlin R, Molldrem J. Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2000 Dec; 26(12):1343-5. PMID: 11223976.
      View in: PubMed
    67. Anderlini P, Giralt S, Andersson B, Ueno NT, Khouri I, Acholonu S, Cohen A, Körbling MJ, Manning J, Romaguera J, Sarris A, Hagemeister F, Mclaughlin P, Cabanillas F, Champlin RE. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease. Bone Marrow Transplant. 2000 Sep; 26(6):615-20. PMID: 11041566.
      View in: PubMed
    68. de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M, Champlin R, Giralt S. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant. Bone Marrow Transplant. 2000 Aug; 26(3):333-8. PMID: 10967575.
      View in: PubMed
    69. Donato ML, Gershenson D, Ippoliti C, Wharton JT, Bast RC, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin RE. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40. PMID: 10849525.
      View in: PubMed
    70. Anderlini P, Donato M, Lauppe MJ, Huh YO, Martin TG, Chan KW, Champlin RE, Körbling M. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors. Br J Haematol. 2000 Jun; 109(4):770-2. PMID: 10929027.
      View in: PubMed
    71. Reiffers J, Labopin M, Sanz M, Korbling M, Blaise D, De La Rubia J, Gorin NC. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis. Bone Marrow Transplant. 2000 Jun; 25(11):1115-9. PMID: 10849522.
      View in: PubMed
    72. Seong CM, Giralt S, Kantarjian H, Xu J, Swantkowski J, Hayes K, Glassman AB, Khouri I, Korbling M, Thall P, Siciliano MJ, Champlin RE. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia. J Clin Oncol. 2000 May; 18(9):1831-6. PMID: 10784623.
      View in: PubMed
    73. Braunschweig I, Mirza NQ, Rondon G, Lauppe J, Mehra R, Gajewski J, Körbling M, Huh YO, Geisler D, Gee AP, Champlin R, Przepiorka D. High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer. Cytotherapy. 2000; 2(2):105-10. PMID: 12042047.
      View in: PubMed
    74. Khouri IF, Lee MS, Romaguera J, Mirza N, Kantarjian H, Korbling M, Albitar M, Giralt S, Samuels B, Anderlini P, Rodriguez J, von Wolff B, Gajewski J, Cabanillas F, Champlin R. Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. Ann Oncol. 1999 Nov; 10(11):1293-9. PMID: 10631455.
      View in: PubMed
    75. Donato ML, Champlin RE, Van Besien KW, Korbling M, Cabanillas F, Anderlini P, Gajewski JG, Lauppe J, Durett A, Andersson B, Giralt S, Khouri I, Hagemeister F, Romaguera JE, Sarris A, McLaughlin P, Younes A, Ippoliti C, Blamble DA, Hester J, Gee A, Rodriguez MA. Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma. Leuk Lymphoma. 1999 Oct; 35(3-4):317-24. PMID: 10706456.
      View in: PubMed
    76. Przepiorka D, Khouri I, Ippoliti C, Ueno NT, Mehra R, Körbling M, Giralt S, Gajewski J, Fischer H, Donato M, Cleary K, Claxton D, Chan KW, Braunschweig I, van Besien K, Andersson BS, Anderlini P, Champlin R. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone Marrow Transplant. 1999 Oct; 24(7):763-8. PMID: 10516680.
      View in: PubMed
    77. Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, Körbling M, Huh YO, Giralt S, Gajewski J, Donato M, Cleary K, Claxton D, Braunschweig I, van Besien K, Andersson BS, Anderlini P, Champlin R. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999 Aug 15; 94(4):1465-70. PMID: 10438735.
      View in: PubMed
    78. Anderlini P, Riggs SA, Körbling M, Champlin R. Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia. Br J Haematol. 1999 Jul; 106(1):159-61. PMID: 10444179.
      View in: PubMed
    79. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Körbling M. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion. 1999 Jun; 39(6):555-60. PMID: 10378833.
      View in: PubMed
    80. Przepiorka D, van Besien K, Khouri I, Hagemeister F, Samuels B, Folloder J, Ueno NT, Molldrem J, Mehra R, Körbling M, Giralt S, Gajewski J, Donato M, Cleary K, Claxton D, Braunschweig I, Andersson B, Anderlini P, Champlin R. Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Ann Oncol. 1999 May; 10(5):527-32. PMID: 10416001.
      View in: PubMed
    81. Przepiorka D, Khouri I, Thall P, Mehra R, Lee MS, Ippoliti C, Giralt S, Gajewski J, van Besien K, Andersson B, Körbling M, Deisseroth AB, Champlin R. Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia. Bone Marrow Transplant. 1999 May; 23(10):977-81. PMID: 10373061.
      View in: PubMed
    82. Körbling M. Collection of allogeneic peripheral blood stem cells. Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun; 12(1-2):41-55. PMID: 11000982.
      View in: PubMed
    83. Körbling M. Allogeneic peripheral blood stem cell transplantation for hematologic diseases. Cancer Treat Res. 1999; 101:1-23. PMID: 10800642.
      View in: PubMed
    84. Przepiorka D, Lu JG, Anderlini P, Körbling M, Donato M, Champlin R, Gee AP, van Vlasselaer P. Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system. Cytotherapy. 1999; 1(2):111-7. PMID: 19746587.
      View in: PubMed
    85. Khouri IF, Romaguera J, Kantarjian H, Palmer JL, Pugh WC, Korbling M, Hagemeister F, Samuels B, Rodriguez A, Giralt S, Younes A, Przepiorka D, Claxton D, Cabanillas F, Champlin R. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol. 1998 Dec; 16(12):3803-9. PMID: 9850025.
      View in: PubMed
    86. Khouri IF, Keating M, Körbling M, Przepiorka D, Anderlini P, O'Brien S, Giralt S, Ippoliti C, von Wolff B, Gajewski J, Donato M, Claxton D, Ueno N, Andersson B, Gee A, Champlin R. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998 Aug; 16(8):2817-24. PMID: 9704734.
      View in: PubMed
    87. Chan KW, Mullen CA, Korbling M. Allogeneic peripheral blood stem cell transplantation for active hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 1998 Aug; 22(3):301-2. PMID: 9720748.
      View in: PubMed
    88. Anderlini P, Przepiorka D, Körbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant. 1998 Jun; 21 Suppl 3:S35-9. PMID: 9712491.
      View in: PubMed
    89. Körbling M. Effects of granulocyte colony-stimulating factor in healthy subjects. Curr Opin Hematol. 1998 May; 5(3):209-14. PMID: 9664162.
      View in: PubMed
    90. Ueno NT, Rondón G, Mirza NQ, Geisler DK, Anderlini P, Giralt SA, Andersson BS, Claxton DF, Gajewski JL, Khouri IF, Körbling M, Mehra RC, Przepiorka D, Rahman Z, Samuels BI, van Besien K, Hortobagyi GN, Champlin RE. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol. 1998 Mar; 16(3):986-93. PMID: 9508181.
      View in: PubMed
    91. Körbling M. In vivo expansion of the circulating stem cell pool. Stem Cells. 1998; 16 Suppl 1:131-8. PMID: 11012155.
      View in: PubMed
    92. Bojko P, Hester JP, Durett AG, Maadani F, Körbling M, Champlin RE. Identification of megakaryocyte precursors in peripheral blood stem cell collections from normal donors. J Clin Apher. 1998; 13(1):7-15. PMID: 9590491.
      View in: PubMed
    93. Woo M, Przepiorka D, Ippoliti C, Warkentin D, Khouri I, Fritsche H, Körbling M. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 1997 Dec; 20(12):1095-8. PMID: 9466284.
      View in: PubMed
    94. Chan KW, Petropoulos D, Choroszy M, Herzog C, Jaffe N, Ater J, Korbling M. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors. Bone Marrow Transplant. 1997 Dec; 20(12):1039-43. PMID: 9466276.
      View in: PubMed
    95. Anderlini P, Körbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, Howe C, Leitman S, Horowitz M, Gluckman E, Rowley S, Przepiorka D, Champlin R. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997 Aug 01; 90(3):903-8. PMID: 9242518.
      View in: PubMed
    96. van Besien K, Thall P, Korbling M, Pugh WC, Khouri I, Mehra R, Giralt S, Anderlini P, Amin K, Mirza N, Seong D, Gajewski J, Hester J, Andersson B, Cabanillas F, Champlin R, Przepiorka D. Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients. Biol Blood Marrow Transplant. 1997 Aug; 3(3):150-6. PMID: 9310192.
      View in: PubMed
    97. Körbling M. Optimal use of cytokines/chemokines in peripheral blood stem cell transplantation. BioDrugs. 1997 Aug; 8(2):107-18. PMID: 18020499.
      View in: PubMed
    98. Giralt S, Estey E, Albitar M, van Besien K, Rondón G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Kørbling M, Keating M, Kantarjian H, Champlin R. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997 Jun 15; 89(12):4531-6. PMID: 9192777.
      View in: PubMed
    99. Khouri IF, Przepiorka D, van Besien K, O'Brien S, Palmer JL, Lerner S, Mehra RC, Vriesendorp HM, Andersson BS, Giralt S, Körbling M, Keating MJ, Champlin RE. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol. 1997 May; 97(2):466-73. PMID: 9163617.
      View in: PubMed
    100. Anderlini P, Przepiorka D, Seong C, Smith TL, Huh YO, Lauppe J, Champlin R, Körbling M. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion. 1997 May; 37(5):507-12. PMID: 9149776.
      View in: PubMed
    101. Anderlini P, Przepiorka D, Lauppe J, Seong D, Giralt S, Champlin R, Körbling M. Collection of peripheral blood stem cells from normal donors 60 years of age or older. Br J Haematol. 1997 May; 97(2):485-7. PMID: 9163620.
      View in: PubMed
    102. Keilholz U, Max R, Scheibenbogen C, Wüster C, Körbling M, Haas R. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer. 1997 Apr 15; 79(8):1617-22. PMID: 9118048.
      View in: PubMed
    103. Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Körbling M. Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant. 1997 Mar; 19(5):455-60. PMID: 9052911.
      View in: PubMed
    104. Anderlini P, Lauppe J, Przepiorka D, Seong D, Champlin R, Körbling M. Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections. Br J Haematol. 1997 Feb; 96(2):415-7. PMID: 9029035.
      View in: PubMed
    105. Giralt S, Weber D, Colome M, Dimopoulos M, Mehra R, Van Besien K, Gajewski J, Andersson B, Khouri I, Przepiorka D, von Wolff B, Delasalle K, Korbling M, Seong D, Alexanian R, Champlin R. Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. J Clin Oncol. 1997 Feb; 15(2):667-73. PMID: 9053492.
      View in: PubMed
    106. de Lima M, van Besien KW, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997 Jan; 19(2):121-7. PMID: 9116608.
      View in: PubMed
    107. Körbling M. Autologous and allogeneic blood stem cell transplantation: potential advantage of blood-over marrow-derived stem cell grafts. Cancer Invest. 1997; 15(2):127-37. PMID: 9095208.
      View in: PubMed
    108. Anderlini P, Körbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells. 1997; 15(1):9-17. PMID: 9007218.
      View in: PubMed
    109. Przepiorka D, Ippoliti C, Khouri I, Anderlini P, Mehra R, Giralt S, Gajewski J, Fritsche H, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Korbling M. Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. Transplantation. 1996 Dec 27; 62(12):1806-10. PMID: 8990368.
      View in: PubMed
    110. Hanania EG, Giles RE, Kavanagh J, Fu SQ, Ellerson D, Zu Z, Wang T, Su Y, Kudelka A, Rahman Z, Holmes F, Hortobagyi G, Claxton D, Bachier C, Thall P, Cheng S, Hester J, Ostrove JM, Bird RE, Chang A, Korbling M, Seong D, Cote R, Holzmayer T, Deisseroth AB, et al. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci U S A. 1996 Dec 24; 93(26):15346-51. PMID: 8986814.
      View in: PubMed
    111. Körbling M, Anderlini P, Durett A, Maadani F, Bojko P, Seong D, Giralt S, Khouri I, Andersson B, Mehra R, vanBesien K, Mirza N, Przepiorka D, Champlin R. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplant. 1996 Dec; 18(6):1073-9. PMID: 8971375.
      View in: PubMed
    112. Anderlini P, Przepiorka D, Champlin R, Körbling M. Peripheral blood stem cell apheresis in normal donors: the neglected side. Blood. 1996 Nov 01; 88(9):3663-4. PMID: 8896438.
      View in: PubMed
    113. Körbling M, Chan KW, Anderlini P, Seong D, Durett A, Langlinais A, Przepiorka D, Gajewski J, Miller P, Sundberg J, Alilaen P, Bojko P, Mirza N, Claxton D, van Besien K, Khouri I, Andersson B, Mehra R, Champlin R. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors. Bone Marrow Transplant. 1996 Nov; 18(5):885-90. PMID: 8932841.
      View in: PubMed
    114. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood. 1996 Oct 15; 88(8):2819-25. PMID: 8874177.
      View in: PubMed
    115. Körbling M. Allogeneic blood stem cell transplantation: the US experience. Hematol Cell Ther. 1996 Oct; 38(5):456-7. PMID: 8915671.
      View in: PubMed
    116. Przepiorka D, Van Vlasselaer P, Huynh L, Durett A, Agbor P, Lauppe J, Valone F, Champlin R, Körbling M. Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system. J Hematother. 1996 Oct; 5(5):497-502. PMID: 8938521.
      View in: PubMed
    117. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan KW, Champlin R, Körbling M. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion. 1996 Jul; 36(7):590-5. PMID: 8701453.
      View in: PubMed
    118. Anderlini P, Przepiorka D, Seong D, Champlin R, Körbling M. Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol. 1996 Jul; 94(1):155-8. PMID: 8757527.
      View in: PubMed
    119. Anderlini P, Przepiorka D, Huh Y, Lauppe J, Miller P, Sundberg J, Seong D, Champlin R, Körbling M. Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol. 1996 Jun; 93(4):940-2. PMID: 8703830.
      View in: PubMed
    120. Körbling M, Fliedner TM. The evolution of clinical peripheral blood stem cell transplantation. Bone Marrow Transplant. 1996 May; 17(5):675-8. PMID: 8733680.
      View in: PubMed
    121. Körbling M. [First steps in clinical gene therapy]. Med Klin (Munich). 1996 Apr 10; 91(4):218-25. PMID: 8692108.
      View in: PubMed
    122. Körbling M, Champlin R. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells. 1996 Mar; 14(2):185-95. PMID: 8991538.
      View in: PubMed
    123. Körbling M, Fliedner TM. The evolution of clinical peripheral blood stem cell transplantation. Bone Marrow Transplant. 1996 Mar; 17 Suppl 2:S4-11. PMID: 8722325.
      View in: PubMed
    124. Frickhofen N, Körbling M, Fliedner TM. Is blood a better source of allogeneic hematopoietic stem cells for use after radiation accidents? Bone Marrow Transplant. 1996 Feb; 17(2):131-5. PMID: 8640157.
      View in: PubMed
    125. Körbling M. Are CD34+ selected cells the better choice for grafting? Cancer Invest. 1996; 14(6):640-1. PMID: 8951368.
      View in: PubMed
    126. Körbling M. Blood stem cell transplantation and gene therapy of cancer. Stem Cells. 1995 Dec; 13 Suppl 3:106-13. PMID: 8747997.
      View in: PubMed
    127. Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondón G, Seong D, Lee M, Gajewski J, Van Besien K, Khouri I, Mehra R, Przepiorka D, Körbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 1995 Dec 01; 86(11):4337-43. PMID: 7492795.
      View in: PubMed
    128. Körbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, Anderlini P, van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995 Oct 01; 86(7):2842-8. PMID: 7545476.
      View in: PubMed
    129. Hegewisch-Becker S, Hanania EG, Fu S, Körbling M, Deisseroth AB, Andreeff M. Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection. Br J Haematol. 1995 Aug; 90(4):876-83. PMID: 7669666.
      View in: PubMed
    130. Korbling M, Przepiorka D, Gajewski J, Champlin RE, Chan KW. With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? Blood. 1995 Aug 01; 86(3):1235. PMID: 7620177.
      View in: PubMed
    131. Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I, et al. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood. 1995 Jun 01; 85(11):3257-63. PMID: 7756658.
      View in: PubMed
    132. Hanania EG, Fu S, Zu Z, Hegewisch-Becker S, Korbling M, Hester J, Durett A, Andreeff M, Mechetner E, Holzmayer T, et al. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene. Gene Ther. 1995 Jun; 2(4):285-94. PMID: 7552989.
      View in: PubMed
    133. van Besien KW, Khouri IF, Giralt SA, McCarthy P, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Bellare N, Nath R, et al. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. J Clin Oncol. 1995 May; 13(5):1096-102. PMID: 7738615.
      View in: PubMed
    134. Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood. 1995 Mar 15; 85(6):1659-65. PMID: 7888684.
      View in: PubMed
    135. Kantarjian HM, Talpaz M, Hester J, Feldman E, Korbling M, Liang J, Rios MB, Smith TL, Calvert L, Deisseroth AB. Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. J Clin Oncol. 1995 Mar; 13(3):553-9. PMID: 7884415.
      View in: PubMed
    136. Drach J, Zhao S, Drach D, Körbling M, Engel H, Andreeff M. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis. Leuk Lymphoma. 1995 Feb; 16(5-6):419-24. PMID: 7540457.
      View in: PubMed
    137. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood. 1994 May 15; 83(10):3068-76. PMID: 7514051.
      View in: PubMed
    138. Körbling M, Drach J, Champlin RE, Engel H, Huynh L, Kleine HD, Berenson R, Deisseroth AB, Andreeff M. Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation. Bone Marrow Transplant. 1994 May; 13(5):649-54. PMID: 7519938.
      View in: PubMed
    139. Pineda A, Korbling M, Rock GA. Transfusion medicine 1994. Rev Invest Clin. 1994 Apr; Suppl:101-15. PMID: 7886293.
      View in: PubMed
    140. Korbling M. Some principles of blood stem cell transplantation. Transfus Sci. 1993 Jan; 14(1):61-4. PMID: 10150143.
      View in: PubMed
    141. Korbling M, Branham C. Quality control in stem cell processing for autotransplantation. Transfus Sci. 1993 Jan; 14(1):101-4. PMID: 10150145.
      View in: PubMed
    142. Körbling M, Juttner C, Henon P, Kessinger A. Autologous blood stem cell versus bone marrow transplantation. Bone Marrow Transplant. 1992; 10 Suppl 1:144-8. PMID: 1355683.
      View in: PubMed
    143. Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett A, Rizzoli V, Alessandrino EP, Bjorkstrand B, et al. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT). Leukemia. 1991 Oct; 5(10):896-904. PMID: 1835746.
      View in: PubMed
    144. Körbling M, Fliedner TM, Holle R, Magrin S, Baumann M, Holdermann E, Eberhardt K. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant. 1991 May; 7(5):343-9. PMID: 1676924.
      View in: PubMed
    145. Körbling M, Knauf W, Funderud S, Kvalheim G, Hunstein W. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia. Haematologica. 1991 Mar; 76 Suppl 1:29-36. PMID: 1650742.
      View in: PubMed
    146. Reiffers J, Korbling M, Labopin M, Gorin NC. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. The EBMT Group Working Party for Autologous Bone Marrow Transplantation. Bone Marrow Transplant. 1991; 7 Suppl 2:144. PMID: 1678976.
      View in: PubMed
    147. Körbling M. [The role of stem cell mobilization in the scope of autologous blood stem cell transplantation]. Beitr Infusionsther. 1991; 28:233-41. PMID: 1725628.
      View in: PubMed
    148. Keilholz U, Klein HG, Körbling M, Brado B, Carter CS, Cullis H, Galm F, Hunstein W. Peripheral blood mononuclear cell collection from patients undergoing adoptive immunotherapy or peripheral blood-derived stem cell transplantation and from healthy donors. J Clin Apher. 1991; 6(3):131-6. PMID: 1686264.
      View in: PubMed
    149. Ho AD, Haas R, Korbling M, Dietz M, Hunstein W. Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation. Bone Marrow Transplant. 1991; 7 Suppl 1:13-7. PMID: 1675138.
      View in: PubMed
    150. Gückel F, Brix G, Semmler W, Ho AD, Körbling M, Georgi M, van Kaick G. Proton chemical shift imaging of bone marrow for monitoring therapy in leukemia. J Comput Assist Tomogr. 1990 Nov-Dec; 14(6):954-9. PMID: 2229574.
      View in: PubMed
    151. Körbling M, Holle R, Haas R, Knauf W, Dörken B, Ho AD, Kuse R, Pralle H, Fliedner TM, Hunstein W. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol. 1990 Jun; 8(6):978-85. PMID: 1971851.
      View in: PubMed
    152. Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood. 1990 Apr 15; 75(8):1606-14. PMID: 2328313.
      View in: PubMed
    153. Pai VR, Korbling M. Autologous bone marrow transplantation (ABMT) in acute myelogenous leukaemia--Heidelberg experience. J Assoc Physicians India. 1990 Apr; 38(4):275-6. PMID: 2202710.
      View in: PubMed
    154. Körbling M, Haas R, Knauf W, Holle R, Hunstein W. Therapeutic efficacy of autologous blood stem cell transplantation (ABSCT): the role of cytotoxic/cytokine stem cell mobilization. Bone Marrow Transplant. 1990 Jan; 5 Suppl 1:39-40. PMID: 1969308.
      View in: PubMed
    155. Knauf WU, Ho AD, Körbling M, Hunstein W. Combination therapy with mitoxantrone and etoposide in adult acute myelogenous leukemia. Haematol Blood Transfus. 1990; 33:314-5. PMID: 1969834.
      View in: PubMed
    156. Körbling M, Dörken B, Ho A, Haas R, Knauf W, Hunstein W. Long-term disease-free survival following autologous bone marrow/blood stem cell transplantation in 89 patients with acute leukemia. Haematol Blood Transfus. 1990; 33:675-8. PMID: 1969835.
      View in: PubMed
    157. Ho AD, Haas R, Wulf G, Knauf W, Ehrhardt R, Heilig B, Körbling M, Schulz G, Hunstein W. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood. 1990 Jan 01; 75(1):203-12. PMID: 2104762.
      View in: PubMed
    158. Körbling M, Hunstein W, Fliedner TM, Cayeux S, Dörken B, Fehrentz D, Haas R, Ho AD, Keilholz U, Knauf W, et al. Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood. 1989 Nov 01; 74(6):1898-904. PMID: 2804340.
      View in: PubMed
    159. Cayeux S, Meuer S, Pezzutto A, Körbling M, Haas R, Schulz R, Dörken B. Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin-2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2. Blood. 1989 Nov 01; 74(6):2278-84. PMID: 2478226.
      View in: PubMed
    160. Cayeux S, Meuer S, Pezzutto A, Körbling M, Haas R, Schulz R, Dörken B. T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2. Blood. 1989 Nov 01; 74(6):2270-7. PMID: 2572284.
      View in: PubMed
    161. Keilholz U, Körbling M, Fehrentz D, Bauer H, Hunstein W. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders. Cancer. 1989 Aug 01; 64(3):641-5. PMID: 2568164.
      View in: PubMed
    162. Gückel F, Semmler W, Brix G, Bachert-Baumann P, Körbling M, Bihl H, van Kaick G. [Bone marrow changes in Hodgkin's disease: MR tomography and chemical shift imaging]. Rofo. 1989 Jun; 150(6):670-3. PMID: 2544941.
      View in: PubMed
    163. Haas R, Ogniben E, Kiesel S, Hohaus S, Baumann M, Körbling M, Dörken B, Hunstein W. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1989 Mar; 17(3):235-9. PMID: 2645156.
      View in: PubMed
    164. Kiesel S, Pezzutto A, Körbling M, Haas R, Schulz R, Hunstein W, Dörken B. Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery. Transplant Proc. 1989 Feb; 21(1 Pt 3):3084-8. PMID: 2565067.
      View in: PubMed
    165. von Herbay A, Dörken B, Mall G, Körbling M. Cardiac damage in autologous bone marrow transplant patients: an autopsy study. Cardiotoxic pretreatment as a major risk factor. Klin Wochenschr. 1988 Dec 01; 66(23):1175-81. PMID: 3062267.
      View in: PubMed
    166. Haas R, Kiesel S, Ogniben E, Baumann M, Hohaus S, Körbling M, Dörken B, Hunstein W. The effect of human recombinant GM-CSF on the myelopoiesis in a long-term bone marrow culture (LTBMC). Behring Inst Mitt. 1988 Aug; (83):278-83. PMID: 3071341.
      View in: PubMed
    167. Kiesel S, Pezzutto A, Moldenhauer G, Haas R, Körbling M, Hunstein W, Dörken B. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood. 1988 Aug; 72(2):672-8. PMID: 2900031.
      View in: PubMed
    168. Berthold F, Bender-Götze C, Dopfer R, Erttmann R, Haas RJ, Henze G, Körbling M, Riehm H, Rister M, Stollmann B, et al. [Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma]. Klin Padiatr. 1988 May-Jun; 200(3):221-5. PMID: 3062259.
      View in: PubMed
    169. Körbling M, Fehrentz D, Rother K, Hunstein W. [Collection and transplantation of hematopoietic stem cells of circulating blood]. Beitr Infusionsther. 1988; 21:322-34. PMID: 2463003.
      View in: PubMed
    170. zum Winkel K, Frey M, Fritz P, Höver KH, Kimmig B, Körbling M, Kuttig H, Mende U, Rieden K, Sturm V, et al. Perspectives of radiotherapy. Arzneimittelforschung. 1987 Feb; 37(2A):263-72. PMID: 3105547.
      View in: PubMed
    171. Ho AD, Lipp T, Ehninger G, Meyer P, Freund M, Illiger HJ, Körbling M. Mitoxantrone and VP-16 in refractory acute myelogenous leukemia. Haematol Blood Transfus. 1987; 30:339-42. PMID: 3305205.
      View in: PubMed
    172. Ho AD, Lipp T, Ehninger G, Meyer P, Rückle H, Steinke B, Kaboth W, Körbling M. Mitoxantrone and VP-16 in refractory acute myelogenous leukemia. Onkologie. 1986 Jun; 9(3):148-50. PMID: 3528961.
      View in: PubMed
    173. Fehrentz D, Körbling M, Weischedel U. Hyperfractionated total body irradiation as part of autologous bone marrow transplantation. Strahlenther Onkol. 1986 Apr; 162(4):246-7. PMID: 3085248.
      View in: PubMed
    174. Körbling M, Dörken B, Ho AD, Pezzutto A, Hunstein W, Fliedner TM. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood. 1986 Feb; 67(2):529-32. PMID: 2867797.
      View in: PubMed
    175. Körbling M, Hunstein W. [Autologous bone marrow transplantation in malignant lymphohematopoietic diseases]. Ter Arkh. 1986; 58(9):23-9. PMID: 3538472.
      View in: PubMed
    176. Kaizer H, Stuart RK, Brookmeyer R, Beschorner WE, Braine HG, Burns WH, Fuller DJ, Korbling M, Mangan KF, Saral R, et al. Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood. 1985 Jun; 65(6):1504-10. PMID: 3888315.
      View in: PubMed
    177. De Fabritiis P, Bregni M, Lipton J, Greenberger J, Nadler L, Rothstein L, Korbling M, Ritz J, Bast RC. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood. 1985 May; 65(5):1064-70. PMID: 3995166.
      View in: PubMed
    178. Körbling M, Hunstein W. In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy. Blut. 1984 Apr; 48(4):189-99. PMID: 6370338.
      View in: PubMed
    179. Körbling M, Hunstein W, Fliedner TM. [Autologous bone marrow transplantation]. Dtsch Med Wochenschr. 1984 Feb 17; 109(7):265-71. PMID: 6141929.
      View in: PubMed
    180. Körbling M, Dörken B, Tischbirek K, Zipperle G, Ho AD, Fliedner TM, Hunstein W. Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells. Blut. 1983 Feb; 46(2):89-93. PMID: 6336961.
      View in: PubMed
    181. Kaizer H, Tutschka P, Stuart R, Korbling M, Braine H, Saral R, Colvin M, Santos G. Autologous bone marrow transplantation in acute leukemia and non-Hodgkin's lymphoma: a phase I study of 4-hydroperoxycyclophosphamide (4HC) incubation of marrow prior to cryopreservation. Haematol Blood Transfus. 1983; 28:90-1. PMID: 6345299.
      View in: PubMed
    182. Körbling M, Hess AD, Tutschka PJ, Kaizer H, Colvin MO, Santos GW. 4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft. Br J Haematol. 1982 Sep; 52(1):89-96. PMID: 6214268.
      View in: PubMed
    183. Körbling M, Burke P, Braine H, Elfenbein G, Santos G, Kaizer H. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol. 1981 Jul; 9(6):684-90. PMID: 6114872.
      View in: PubMed
    184. Tutschka PJ, Körbling M, Hess AD, Beschorner WE, Santos GW. Prevention of graft-versus-host disease (GVHD) by chemoseparation of marrow cells. Transplant Proc. 1981 Mar; 13(1 Pt 2):1202-6. PMID: 7022926.
      View in: PubMed
    185. Niethammer D, Bienzle U, Rodt H, Goldmann SF, Körbling M, Flad HD, Netzel B, Haas RJ, Fischer K, Poschmann A, Fliedner TM, Thierfelder S, Kleihauer E. Rhesus incompatibility and aplastic anemia as the consequence of split chimerism after bone-marrow transplantation for severe combined immunodeficiency. Thymus. 1980 Sep; 2(2):75-82. PMID: 6777909.
      View in: PubMed
    186. Körbling M, Fliedner TM, Rüber E, Pflieger H. Description of a closed plastic bag system for the collection and cryopreservation of leukapheresis-derived blood mononuclear leukocytes and CFUc from human donors. Transfusion. 1980 May-Jun; 20(3):293-300. PMID: 7385323.
      View in: PubMed
    187. Körbling M, Fliedner TM, Pflieger H. Collection of large quantities of granulocyte/macrophage progenitor cells (CFUc) in man by means of continuous-flow leukapheresis. Scand J Haematol. 1980 Jan; 24(1):22-8. PMID: 7367828.
      View in: PubMed
    188. Körbling M, Fliedner TM, Calvo W, Ross WM, Nothdurft W, Steinbach I. Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): long-term allogeneic engraftment without GVH-reaction. Exp Hematol. 1979 Jul; 7(6):277-88. PMID: 39771.
      View in: PubMed
    189. Fliedner TM, Calvo W, Körbling M, Nothdurft W, Pflieger H, Ross W. Collection, storage and transfusion of blood stem cells for the treatment of hemopoietic failure. Blood Cells. 1979 Jun 15; 5(2):313-28. PMID: 45349.
      View in: PubMed
    190. Fliedner TM, Körbling M, Arnold R, Grilli G, Haen M, Kreutzmann H, Pflieger H. Collection and cryopreservation of mononuclear blood leukocytes and of CFU-C in man. Exp Hematol. 1979; 7 Suppl 5:398-408. PMID: 263245.
      View in: PubMed
    191. Nothdurft W, Fliedner TM, Calvo W, Flad HD, Huget R, Körbling M, Krumbacher-von Loringhofen K, Ross WM, Schnappauf HP, Steinbach I. CFU-C populations in blood and bone marrow of dogs after lethal irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells. Scand J Haematol. 1978 Aug; 21(2):115-30. PMID: 694423.
      View in: PubMed
    192. Ross WM, Koerbling M, Nothdurft W, Fliedner TM. The role of dextran sulfate in increasing the CFUc-concentration in dog blood. Proc Soc Exp Biol Med. 1978 Feb; 157(2):301-5. PMID: 622398.
      View in: PubMed
    193. Abt C, Arnold R, Flad HD, Fliedner TM, Goldmann SF, Heimpel H, Kleihauer E, Korbling M, Kubanek B, Lohrmann HP, Niethammer D, Pflieger H. Bone marrow transplantation for severe aplastic anemia: Ulm experience [proceedings]. Pathol Biol (Paris). 1978 Jan; 26(1):40-1. PMID: 358081.
      View in: PubMed
    194. Körbling M, Ross W, Pflieger H, Arnold R, Fliedner TM. Procurement of human blood stem cells by continuous-flow centrifugation--further comment. Blood. 1977 Oct; 50(4):753-4. PMID: 901947.
      View in: PubMed
    195. Fliedner TM, Körbling M, Calvo W, Bruch C, Herbst E. Cryopreservation of blood mononuclear leukocytes and stem cells suspended in a large fluid volume. A preclinical model for a blood stem cell bank. Blut. 1977 Sep 29; 35(3):195-202. PMID: 912104.
      View in: PubMed
    196. Körbling M, Fliedner TM, Calvo W, Nothdurft W, Ross WM. In-vitro and in-vivo properties of canine blood mononuclear leukocytes separated by discontinuous albumin density gradient centrifugation. Biomedicine. 1977 Jul; 26(4):275-83. PMID: 21710.
      View in: PubMed
    197. Rodt H, Netzel B, Niethammer D, Körbling M, Götze D, Kolb HJ, Thiel E, Haas RJ, Fliedner TM, Thierfelder S. Specific absorbed antithymocyte globulin for incubation treatment in human marrow transplantation. Transplant Proc. 1977 Mar; 9(1):187-91. PMID: 17192.
      View in: PubMed
    198. Fliedner TM, Flad HD, Bruch C, Calvo W, Goldmann SF, Herbst E, Hügl E, Huget R, Körbling M, Krumbacher K, Nothdurft W, Ross WM, Schnappauf HP, Steinbach I. Treatment of aplastic anemia by blood stem cell transfusion: a canine model. Haematologica. 1976 Jun; 61(2):141-56. PMID: 7516.
      View in: PubMed
    199. Expression of multidrug resistance (mdr-1) and p53 genes in hematologic cell systems. Cancer Bulletin. 45:131-138.
    200. Fludarabine (famp)-based chemotherapy at conventional doses allows engraftment of allogeneic (allo) peripheral blood progenitor cell (pbpc) transplantation in chronic lymphocytic leukemia (cll). Experimental Hematology. 24:1046.
    201. Autologous blood stem cell transplantation (ABSCT) in 34 patients. Bone Marrow Transplantation. 3.
    202. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22:2159-2164.
    203. Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells. Blut. 46:89-93.
    204. Effect of 4-hydroperoxycyclophosphamide (4-HC) on hemopoietic stem cells.
    205. Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion. Leukemia and Lymphoma. 56:711-715.
    206. Transplantation of hemapheresis-derived hemopoietic stem cells. Plasma Therapy and Transfusion Technology. 9:119-132.
    207. Allogeneic blood stem cell transplantation. Infusionstherapie und Transfusionsmedizin. 24:244.
    208. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer. 122:3316-3326.
    209. Allogeneic peripheral blood stem cell transplantation. FORUM - Trends in Experimental and Clinical Medicine. 7:184-198.
    210. A median two year follow-up evaluation of 42 patients with acute leukaemia following ABMT. Bone Marrow Transplantation. 3.
    211. Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia (CLL). Blood. 96.
    212. Filgrastim alone versus chemotherapy plis filgrastim for peripheral blood stem cell mobilization in multiple myeloma. Blood. 96.
    213. Circulating blood cells for tissue repair. Biomedicine and Pharmacotherapy. 56:265.
    214. Transplantation of blood-derived hematopoietic stem cells. Bone Marrow Transplantation. 15.
    215. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy (Proceedings of the National Academy of Sciences (December 24, 1996) 93 (15346-15351)). Proceedings of the National Academy of Sciences of the United States of America. 94:5495.
    216. A mathematical model for the progression of an abnormality in the hematopoietic system. Lecture Notes in Control and Information Sciences. 321:257-267.
    217. Comparison of survival in patients with t cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease. Biology of Blood and Marrow Transplantation. 21:855-859.
    218. Induction of graft-versus-leukemia using flu-darabine-based allogeneic mini-transplants as treatment for lymphoid malignancies. Experimental Hematology. 25:735.
    219. Peripheral blood stem cells. Oncologist. 2:104-113.
    220. Significance of total nucleated cell dose from marrow harvests on outcome and engraftment in patients with acute leukemia undergoing autologous bone marrow transplantation. Blood. 96.
    221. Allogeneic hematopoietic transplantation for indolent lymphomas. Blood. 96.
    222. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. International Journal of Cell Cloning. 10:111-113.
    223. An analysis of factors correlated with the collection of peripheral blood progenitor cells (pbpcs) from normal donors. Experimental Hematology. 24:1046.
    KORBLING's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description